Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions

Abstract

This study identified CYP2C variants, including CYP2C9*3, known to reduce drug clearance, as important genetic factors associated with phenytoin-related severe cutaneous adverse reactions.